Will the NSF's new Ph.D. model be considered successful by August 1, 2028?

This market resolves to Yes if the AI-discovered natural molecule identified by Stanford scientists as having Ozempic-like effects without typical side effects receives FDA approval by July 31, 2027. The market resolves to No if approval has not been granted by this date.

This market resolves to Yes if Stanford Medicine or another reputable institution publicly confirms that the AI-discovered molecule, which mimics the effects of Ozempic without the side effects, receives approval to commence clinical trials by September 30, 2026. The resolution will be based on announcements from institutions, regulatory bodies, or credible science news sources.

This market resolves to Yes if any official regulatory body approves the AI-discovered natural molecule for weight loss treatment by December 31, 2026. This molecule is designed to mimic Ozempic-like effects without the side effects, as reported in recent research from Stanford scientists.

Will China's government announce new regulations on experimental gene therapies by August 31, 2026?

This market resolves to Yes if an official announcement of new regulations or restrictions on experimental gene therapies is made by China's government and reported by major reputable news outlets (e.g., Xinhua News, SCMP) by August 31, 2026. The market resolves to No if no such announcement is made by the deadline.

Will new regulations on gene therapy clinical trials be announced in China by September 30, 2026?

This market resolves to Yes if the Chinese government publicly announces new regulations or guidelines for the approval, oversight, or conduct of gene therapy clinical trials by September 30, 2026. The announcement must be reported in credible news outlets or official government channels.

Will the U.S. allocate at least $1 billion more in AI-focused 'Genesis Mission' grants by September 30, 2026?

This market resolves to Yes if, by September 30, 2026, public announcements or official documentation confirm that the U.S. government has allocated at least an additional $1 billion specifically toward AI projects under the 'Genesis Mission' program since its initial unveiling in July 2026. Allocations must be explicitly tied to this initiative.